ProfileGDS5822 / ILMN_2756396
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 33% 21% 38% 19% 30% 6% 9% 7% 46% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 116.233
GSM1276600PDAC Late Ablation Control 21521
GSM1276601PDAC Late Ablation Control 313.238
GSM1276602PDAC Late Ablation 111.219
GSM1276603PDAC Late Ablation 215.230
GSM1276604PDAC Late Ablation 36.16
GSM1303940PDAC Late Ablation_anti-CTLA4 199
GSM1303941PDAC Late Ablation_anti-CTLA4 25.57
GSM1303942PDAC Late Ablation_anti-CTLA4 323.146